Swander Pace Capital has sold its portfolio company ReNew Life Formulas, a maker of probiotics and other digestive care supplements, to The Clorox Company for $290 million. In calendar year 2015, Renew Life had revenues of $115 million.
ReNew Life produces and sells digestive health products and functional foods including probiotic supplements, herbal cleansing products, digestive enzymes, oil supplements, fiber supplements, and other specialty supplements. The company sells its products through health food stores and retailers throughout the United States, as well as an online store. The company was founded in 1997 by Brenda and Stan Watson and is headquartered near Tampa in Palm Harbor, FL (www.renewlife.com).
Swander Pace acquired ReNew Life in April 2008. According to Swander Pace, during the firm’s eight year ownership term, Renew Life grew to become the No. 1 brand of probiotics in the natural channel, with a rapidly growing share in the food, drug and mass channel. Probiotic products represent about two-thirds of current Renew Life sales.
The fragmented digestive supplement market currently has sales of at least $10 billion in the US alone and is growing at about 7 percent annually. The probiotics subcategory, which is $1.3 billion in the US, is expected to grow at 15 percent per year.
“This sale to Clorox is the culmination of years of dedication to growing a company focused on improving lives through better digestive health,” said Corby Reese, managing director at Swander Pace. “Stan and Brenda Watson were decades ahead of the mainstream when they founded Renew Life, and the company has been instrumental in bringing probiotics and digestive health into much broader public awareness. We’re proud to have worked with the Renew Life team to build such a respected industry leader.”
Swander Pace invests in middle-market consumer products companies including branded and non-branded manufacturers, marketers, and distributors that sell through a range of retail and institutional channels. The firm generally targets companies that have up to $400 million in revenues. Swander Pace has raised over $1.3 billion of equity capital through five private equity funds and has led investments in more than 40 consumer products companies. Swander Pace was founded in 1996 and has offices in San Francisco; Bedminster, NJ; and near Toronto in Oakville, ON (www.spcap.com).
“The Swander Pace team has been an incredible partner to help us reach new heights,” said Ron Fugate, Renew Life’s CEO. “Their guidance and operational expertise set us on a path for accelerated growth and allowed us to attract the interest of Clorox, a strategic partner with a tremendous track record in best-in-class consumer products.”
The Clorox Company (NYSE: CLX) is a multinational manufacturer and marketer of consumer and professional products with approximately 7,700 employees worldwide and annual sales of $5.7 billion. The company is headquartered in Oakland, CA (www.clorox.com).
Rothschild (www.rothschild.com) was the financial advisor to Swander Pace on the transaction.
© 2016 Private Equity Professional • Private Equity’s Leading News Magazine • 5-5-16